Division No. 11, AB, CA
Small Business (1-10M TTM Revenue)
Osteometabolix Pharmaceuticals Inc. (OMX) is a university spin-off company focused on the development, formulation and evaluation of bone-targeting biologics for bone conditions such as Osteoporosis, Paget’s disease, and Osteoarthritis.
|Osteometabolix Pharmaceuticals Edmonton, AB, Canada|
|Osteometabolix Pharmaceuticals Division No. 11, AB, Canada|
To request access, simply fill out the form below and we will contact you.